ALEXANDER ARHETS: Open Payments
NPI 1013956853 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,710 in 75 payments from 11 companies in 2025. Trend: 2023 $2,582 · 2024 $4,653 · 2025 $2,710
Food & beverage: $2,579Education: $131
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $635 |
| Janssen Biotech, Inc. | 8 | $563 |
| ABBVIE INC. | 27 | $543 |
| Novartis Pharmaceuticals Corporation | 14 | $335 |
| Arcutis Biotherapeutics, Inc. | 4 | $187 |
| Organon LLC | 4 | $156 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
| Galderma Laboratories, L.P. | 4 | $66 |
| LEO Pharma Inc. | 3 | $59 |
| Incyte Corporation | 2 | $47 |
Products named: TREMFYA, SKYRIZI, REPATHA, RINVOQ, VTAMA, Rhapsido, DUPIXENT, Zoryve.
Industry payments across ID — which companies pay providers there.
